Close

MCV

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The molluscum contagiosum virus (MCV) is a species of virus in the poxvirus family, which causes the disease molluscum contagiosum in humans. There are 4 types of MCV, MCV-1 through -4. MCV-1 is the most prevalent in human infections, and MCV-2 is seen usually in adults and often sexually transmitted. Virions have a complex structure that is consistent with the structure of the other members of the poxvirus family: a surface membrane, a core, and lateral bodies. The virus may be contained within inclusion bodies and mature by budding through the membrane of the host cell, giving rise to a large amount of viral shedding in a short period of time.
  • TCR Vector Products

  • TCR Cell Products

Loading...
  • Target Species:
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-ZP006 Human anti-MCV T cell receptor (SMF-48), pCDTCR1 MCV SMF-48 Human SMFDEVDEA HLA-A02 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP007 Human anti-MCV T cell receptor (SMF-72), pCDTCR1 MCV SMF-72 Human SMFDEVDEA HLA-A03 Lentiviral vector   Add to Cart   Datasheet
TCR-ZP008 Human anti-MCV T cell receptor (KLL-85), pCDTCR1 MCV KLL-85 Human KLLEIAPNC HLA-A03 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.